Integrated transcriptomic and network analysis reveals candidate immune–metabolic biomarkers in children with the inattentive type of ADHD

The study identified CD180 and COA3 as candidate biomarkers for ADHD-I, which may provide new clues into the mechanism of ADHD-I and potential therapeutic targets.

Authors

Institutions

Publication Details

Journal
Frontiers in Psychiatry
Published
2025-10-02
DOI
https://doi.org/10.3389/fpsyt.2025.1642817
Citations
1
Primary Topic
Attention Deficit Hyperactivity Disorder
Type
article
Field-Weighted Citation Impact
1.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrated transcriptomic and network analysis reveals candidate immune–metabolic biomarkers in children with the inattentive type of ADHD

Qiaoyan Shao, Xiaoxia Nina Lin, Yanhui Chen
1 citations
Frontiers in Psychiatry
Attention Deficit Hyperactivity Disorder
1.47
article

Integrated transcriptomic and network analysis reveals candidate immune–metabolic biomarkers in children with the inattentive type of ADHD

Qiaoyan Shao, Xiaoxia Nina Lin, Yanhui Chen
article en
1 citations

Abstract

The study identified CD180 and COA3 as candidate biomarkers for ADHD-I, which may provide new clues into the mechanism of ADHD-I and potential therapeutic targets.

Frontiers in PsychiatryVol. 16
Fujian Medical University (CN), First Affiliated Hospital of Fujian Medical University (CN), Union Hospital (CN)
Natural Science Foundation of Fujian Province
Openalex Percentile: Top 15%
Attention Deficit Hyperactivity Disorder
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.